SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

09 Jan 2025 Evaluate
The revenue declined to Rs. 122.12 millions for the quarter ended December 2024 as compared to Rs. 127.06 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 8.95 millions from Rs. 13.22 millions, a decline of -32.30% on QoQ basis.A decline of 56.23 millions was observed in the OP in the quarter ended December 2024 from 64.08 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 122.12 127.06 -3.89 343.81 333.30 3.15 448.81 516.22 -13.06
Other Income 0.08 0.30 -73.33 46.51 0.30 15403.33 0.39 0.36 8.33
PBIDT 56.23 64.08 -12.25 203.11 157.84 28.68 211.23 215.23 -1.86
Interest 18.38 22.22 -17.28 58.23 62.60 -6.98 77.78 76.51 1.66
PBDT 37.85 41.86 -9.58 144.88 95.24 52.12 133.45 138.72 -3.80
Depreciation 22.48 22.76 -1.23 67.71 68.64 -1.35 92.91 92.66 0.27
PBT 15.37 19.10 -19.53 77.17 26.60 190.11 40.54 46.06 -11.98
TAX 6.42 5.88 9.18 13.32 8.36 59.33 15.33 19.72 -22.26
Deferred Tax 0.28 -0.09 -411.11 -2.62 -1.11 136.04 -1.43 9.41 -115.20
PAT 8.95 13.22 -32.30 63.85 18.24 250.05 25.21 26.34 -4.29
Equity 161.29 149.04 8.22 161.29 149.04 8.22 149.04 149.04 0.00
PBIDTM(%) 46.04 50.43 -8.70 59.08 47.36 24.75 47.06 41.69 12.88

Vivo Bio Tech Share Price

29.42 0.50 (1.73%)
17-Apr-2026 10:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.90
Dr. Reddys Lab 1223.40
Cipla 1240.40
Zydus Lifesciences 945.90
Lupin 2332.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×